Thursday, April 30, 2015

KANEH BOSEM - The Fragrant Cane is the Cannabis plant.


The following embed is from  A cyclopædia of biblical literature, ed. by J. Kitto.  I would like others to know the true history of this and its rightful place on all of our shelves to use.  It is non toxic and highly beneficial for numerous reasons.  Still governments protest it being a poisonous plant.  A Privet shrub is a poisonous tree and it near killed my dog, Cannabis is in no way containing the types of toxic alkaloids that constitute a poison.  In fact cannabis is extremely the opposite of this and further to this there is no way that a person can overdose on cannabis making it the safest substance on the planet to utilize. 

To read more on that please find text after the embed further to this research on cannabis.



10 Biggest Pot Myths, Debunked by Science
By Paul Armentano
via AlterNet
May 13, 2014

Medical cannabis opponents are fond of promoting many myths and misconceptions about the herb.
Here are the facts:

1. "Medical cannabis is too dangerous to recommend as a medicine"
The cannabis plant and its biologically active constituents, known as cannabinoids, possess an impressive safety profile compared to other conventional therapeutic agents.
According to the National Academy of Sciences, Institute of Medicine, marijuana possesses an estimated dependence liability of less than ten percent.
(Others have acknowledged that pot’s true dependence potential is likely even lower.)
This percentage is approximately the same as anxiolytic drugs like Xanax and Valium and far lower than that of many other licit prescription drugs or recreational substances, like alcohol (15 percent) and tobacco (32 percent).
Moreover, unlike the active compounds in many conventional prescription medicines, cannabinoids are relatively non-toxic to fully developed healthy cells and organs.
Cannabis also possesses no lethal overdose potential.
As acknowledged by no less than the DEA’s own administrative law judge, “Marijuana, in its natural form, is one of the safest therapeutically active substances known to man.”
2. "Medical marijuana hasn’t yet been subjected to adequate scientific study"
Cannabis possesses a far longer history of human use as a safe and effective therapeutic agent than virtually any comparable substance.
Archeologists have identified cannabis-based textiles dating to 7,000 B.C. in northern China and the plant's use as a medicinal and agent date back nearly as far.
For example, in 2008, archeologists in Central Asia discovered over two pounds of cannabis buried in the 2,700-year-old grave of an ancient mummified shaman.
After conducting extensive testing on the material's potency, researchers affirmed, "The most probable conclusion ... is that ancient cultures cultivated cannabis for pharmaceutical, psychoactive, and divinatory purposes."
In addition, the marijuana plant is also one of the most studied biologically active substances of modern times.
A search on PubMed, the repository for all peer-reviewed scientific papers, using the term “marijuana” yields nearly 20,000 scientific papers referencing the plant and/or its constituents, nearly half of which have been published just within the past decade.
By comparison, a keyword search using the term “Tylenol” yields 17,370 published papers.
A keyword search using the term “ibuprofen’ yields 10,500 published paper.
A keyword search using the term “Ritalin” yields 7,012 published papers, and a keyword search using the term “hydrocodone” yields only 630 published papers.
3. "There aren’t sufficient clinical trials evaluating pot’s safety and efficacy as a medicine"
More than 100 controlled trials, involving thousands of subjects, have evaluated the safety and efficacy of cannabis and/or individual cannabinoids.
Most recently, a review of FDA-approved pot trials conducted by various California Universities concluded, “Based on evidence currently available the Schedule I classification (for cannabis) is not tenable; it is not accurate that cannabis has no medical value, or that information on safety is lacking.”
This body of clinical evidence exceeds that of many FDA-approved prescription drugs.
According to a 2014 review published in the Journal of the American Medical Association, of the 188 novel therapeutic agents approved by the FDA between the years 2005 to 2012, “The median number of pivotal trials per indication was two and 74 indications (37%) were approved on the basis of a single trial.”
4. "No major medical or health organizations support medical marijuana access "
Numerous medical and health organizations – such as the American Nurses Association, the American Public Health Association, and the Epilepsy Foundation of America – support allowing qualified patients to legally access to cannabis therapy.
Most practicing physicians do too.
According to survey data released this year by WebMD/Medscape, nearly 70 percent of doctors, including over 80 percent of oncologists and hematologists, acknowledge the therapeutic qualities of cannabis and 56 percent agree that it should be a legal option for patients.
5. "Medical cannabis laws are associated with increased crime"
Not so concludes a study published earlier this year in the scientific journal PLoS ONE.
Investigators tracked crime rates across all 50 states in the years between 1990 and 2006, during which time 11 states legalized medical cannabis access.
Authors reviewed FBI Uniform Crime Report data to determine whether there was any association between the enactment of medical pot laws and rates of statewide criminal activity, specifically the number of reported crimes involving homicide, rape, robbery, assault, burglary, larceny, and auto theft.
They concluded, “The central finding gleaned from the present study was that MML (medical marijuana legalization) is not predictive of higher crime rates and may be related to reductions in rates of homicide and assault. … These findings run counter to arguments suggesting the legalization of marijuana for medical purposes poses a danger to public health in terms of exposure to violent crime and property crimes.”
Similarly, a 2012 federally commissioned study reported that the establishment of cannabis dispensaries is not associated with elevated rates of either violent crimes or property crimes.
It concluded, “There were no observed cross-sectional associations between the density of medical marijuana dispensaries and either violent or property crime rates in this study. These results suggest that the density of medical marijuana dispensaries may not be associated with crime rates.”
6. "Medical cannabis laws increase pot use by adolescents"
Wrong again.
Writing in the Journal of Adolescent Health in April, researchers at Rhode Island Hospital and Brown University assessed the impact of medical cannabis laws over a 20-year period by examining trends in self-reported drug use by high schoolers in a cohort of states before and after legalization.
Investigators compared these trends to geographically matched states that had not adopted medical marijuana access laws during this time.
They determined, “Our study of self-reported marijuana use by adolescents in states with a medical marijuana policy compared with a sample of geographically similar states without a policy does not demonstrate increases in marijuana use among high school students that may be attributed to the policies. … Concerns about (medical marijuana laws) ‘sending the wrong message’ may have been overblown.”
7. "Inhaling medical cannabis significantly damages the lungs"
According to a 2012 study published in the Journal of the American Medical Association, subjects exposed to moderate levels of cannabis smoke over an extended period of time do not experience the sort of significant pulmonary harms associated with tobacco smoking.
"Our findings suggest that occasional use of marijuana ... may not be associated with adverse consequences on pulmonary function," the study concluded.
Further, the long-term inhalation of pot smoke is not associated with increased incidents of lung-related cancers.
According to the results of the largest case-controlled study ever to investigate the matter, ganja smoking is not associated with higher incidences of cancers of the lung or upper aero-digestive tract, even among subjects who reported smoking more than 22,000 joints over their lifetime.
Summarizing the study’s findings to the Washington Post, the study's lead researcher, Dr. Donald Tashkin of the University of California at Los Angeles affirmed: "We hypothesized that there would be a positive association between marijuana use and lung cancer, and that the association would be more positive with heavier use. What we found instead was no association at all, and even a suggestion of some protective effect."
8. "No medicine is smoked"
Yet patients inhale many conventional medications, such as anti-asthma drugs.
These patients inhale conventional medications for largely the same reasons as do medical cannabis smokers: they require rapid onset of therapeutic drug effect, they desire the flexibility to self-regulate their dosage depending on the circumstances, and the medication they are administering lacks lethal overdose potential.
Further, clinical studies assessing the efficacy of vaporization as a cannabinoid delivery device have determined it to be a safe alternative to smoking, concluding: “Vaporization of marijuana does not result in exposure to combustion gases and [was] preferred by most subjects compared to marijuana cigarettes. … [It] is an effective and apparently safe vehicle for THC delivery.”
9. "There is no legitimate need for medical cannabis because Marinol is already available by prescription"
Marinol is an FDA-approved synthetic version of a single isolated compound in cannabis.
Consequently, Marinol lacks dozens of other identified, therapeutically active components available in the plant, as well many of the terpenes present in pot.
It possesses poor bioavailability compared to inhaled plant cannabinoids, and its mood-altering effects tend to be far more dysphoric.
Not surprisingly, when given the choice between Marinol and whole-plant cannabis, the majority of patients choose the herbal alternative.
10. "Cannabis isn’t medicine because the FDA has not approved its therapeutic use"
The FDA evaluates patented, synthetic products developed by private companies.
It does not evaluate naturally occurring botanical products such as cannabis.
Of course, that is not to say that the plant, in particular a standardized variety of the herb, could not arguably meet the conventional FDA standards of safety and efficacy.
After all, humans have consumed cannabis for thousands of years and it possesses adequate safety profile.
Further, its therapeutic utility is demonstrated in numerous controlled trials.
Arguably, by any objective analysis, cannabis and cannabinoids exceed the FDA’s existing standards for safety and efficacy.

Wednesday, April 29, 2015

Getting High on the Endocannabinoid System

CANNABIS CURES CANCERS!'s photo.

Getting High on the Endocannabinoid System
by Bradley E. Alger, Ph.D.
Cerebrum: the Dana Forum on Brain Science
Nov. - Dec. 2013
Editor’s Note:
The endogenous cannabinoid system—named for the plant that led to its discovery—is one of the most important physiologic systems involved in establishing and maintaining human health.
Endocannabinoids and their receptors are found throughout the body: in the brain, organs, connective tissues, glands, and immune cells.
With its complex actions in our immune system, nervous system, and virtually all of the body’s organs, the endocannabinoids are literally a bridge between body and mind.
By understanding this system, we begin to see a mechanism that could connect brain activity and states of physical health and disease.
------------------------------------------------------
Cannabis, derived from a plant and one of the oldest known drugs, has remained a source of controversy throughout its history. 
From debates on its medicinal value and legalization to concerns about dependency and schizophrenia, cannabis (marijuana, pot, hashish, bhang, etc.) is a hot button for politicians and pundits alike.

Fundamental to understanding these discussions is how cannabis affects the mind and body, as well as the body’s cells and systems.
How can something that stimulates appetite also be great for relieving pain, nausea, seizures, and anxiety?

Whether its leaves and buds are smoked, baked into pastries, processed into pills, or steeped as tea and sipped, cannabis affects us in ways that are sometimes hard to define.

Not only are its many facets an intrinsically fascinating topic, but because they touch on so many parts of the brain and the body, their medical, ethical, and legal ramifications are vast.

The intercellular signaling molecules, their receptors, and synthetic and degradative enzymes from which cannabis gets its powers had been in place for millions of years by the time humans began burning the plants and inhaling the smoke.

Despite records going back 4,700 years that document medicinal uses of cannabis, no one knew how it worked until 1964.

That was when Yechiel Gaoni and Raphael Mechoulam reported that the main active component of cannabis is tetrahydrocannabinol (THC).

THC, referred to as a “cannabinoid” (like the dozens of other unique constituents of cannabis), acts on the brain by muscling in on the intrinsic neuronal signaling system, mimicking a key natural player, and basically hijacking it for reasons best known to the plants.

Since the time when exogenous cannabinoids revealed their existence, the entire natural complex came to be called the “endogenous cannabinoid system,” or “endocannabinoid system” (ECS).

THC is a lipid, but in 1964, known or suspected neurotransmitters and neuromodulators were water-soluble molecules—peptides, amino acids, or amines—not lipids.

Ordinary neuroactive agents interact with cells by binding to specific proteinaceous receptor molecules that are part of the cell surface.  Each receptor has an intricate structural pocket into which a particular neurotransmitter fits.  The interaction triggers the biochemical and biophysical reactions that affect the physiological properties of the cell.

Lipids avoid water, and individual lipid molecules might simply drift freely around in a compatible lipophilic environment, such as the cell surface membrane, without having much to do with proteins.  How could they influence neuronal behavior?

The best scientific guess at the time was that molecules such as THC would owe their psychotropic actions to “membrane fluidizing” properties, a vague notion that would not explain specificity of action, among other things.

Nevertheless, strong evidence that THC and similar synthetic molecules could bind tightly to specific sites in the brain emerged, implying that THC does indeed work through true receptors. This hypothesis was confirmed in 1990 with the isolation and cloning of the first cannabinoid receptor, CB1, and later of CB2.

In the central nervous system (CNS), CB1 is by far the predominant form, although it also exists outside the CNS; CB2 is primarily found outside the CNS, and is associated with the immune system.

Both receptor subtypes are 7-transmembrane domain macromolecules of the “G-protein-coupled” class.  Unexpectedly, CB1 turned out to be one of the most abundant G-protein-coupled receptors in the brain.  It was immediately obvious that CB1 and CB2 must partner with an endogenous ligand, a natural agent for which they would normally act as the proper receptors. They did not evolve to react with rarely ingested, plant-derived chemicals.  Indeed, Mechoulam’s group isolated an arachidonic acid derivative (N-arachidonoylethanolamide, “anandamide”) that activated CB1, and a second endogenous CB1 ligand two-arachidonolyl glycerol (2-AG) was later discovered.

These endocannabinoids are the major physiological activators of CB1 and CB2, yet they are not standard neurotransmitters.

For one thing, like THC, they are lipids, and brain cells, mainly neurons, are surrounded by an aqueous solution, an inhospitable environment for an intercellular lipid messenger.
More surprisingly, endocannabinoids go against the flow of typical chemical synaptic signaling.  A neuron that releases a chemical neurotransmitter (say, GABA or glutamate) is designated as “pre-synaptic”; the target neuron that expresses receptors for that neurotransmitter is “postsynaptic.”

Endocannabinoids, however, are synthesized and released from postsynaptic cells, and travel backward (in the “retrograde” direction) across the synapse, where they encounter CB1s located on adjacent nerve terminals.

Physiologically, CB1Rs act as communications traffic cops. Precisely positioned in synaptic regions, they inhibit the release of many excitatory and inhibitory neurotransmitters.  Thus, by releasing endocannabinoids, postsynaptic target cells can influence their own incoming synaptic signals.

CB1 is densely located in the neocortex, hippocampus, basal ganglia, amygdala, striatum, cerebellum, and hypothalamus. These major brain regions mediate a wide variety of high-order behavioral functions, including learning and memory, executive function decision making, sensory and motor responsiveness, and emotional reactions, as well as feeding and other homeostatic processes.

Within neuronal circuits, suppression of excitatory transmitter release tends to dampen excitation, while suppression of inhibitory transmitter release favors neuronal network excitation.  Given the enormous complexity of the brain, the endocannabinoid system could affect behavior in an almost limitless number of ways:

Simple generalizations of what will happen when CB1 receptors are globally turned on or off are not feasible.  The challenge for developers of cannabinoid-based medicines is to find beneficial ways to exploit this powerful yet convoluted feedback system.

From a therapeutic point of view, the near ubiquity of the endocannabinoid system has good news/bad news implications.  Good news because it offers explanatory power—the ability to make sense of numerous yet quite different aspects of neural processing involving the endocannabinoid system in normal brains and, conversely, to offer insight into a variety of maladies that accompany its dysfunction.  Bad news because wide heterogeneous dispersion greatly complicates the task of targeting this system for specific therapeutic purposes.  Side effects are therefore common and problematic.

CB1 and Obesity

Obesity is a serious worldwide health concern.

An attempt to develop an endocannabinoid system–based strategy to solve it provides a textbook example of the promise and the problems involved.  The feeding control centers in the hypothalamus express high concentrations of CB1.

These receptors are responsible for “the munchies,” the craving for food that is stimulated by cannabis use. But they also prompt the normal desire to eat.  Preventing the activation of hypothalamic CB1s should decrease eating.  In addition, CB1 receptors outside the brain regulate energy metabolism in the liver and fat tissue, and pharmacologically blocking these peripheral receptors in animal studies results in less body weight gain even when the same amount of food was eaten.

Researchers at the pharmaceutical company Sanofi-Aventis gave the CB1 antagonist rimonabant to obese individuals in multi-year, multi-thousand-patient trials and obtained stunning results.  The drug worked brilliantly; patients lost weight and girth.
Negative side effects (depression, anxiety, and nausea) occurred in 10 percent of the users, but they were not life-threatening and the risks were deemed worth the rewards.

Rimonabant (marketed as “Acomplia®” among other names) became readily available in 56 countries in 2006, and Sanofi’s stock soared.  When approached to approve sale in the United States, however, the Food and Drug Administration (FDA) was skeptical and asked for more information about the drug’s performance after the clinical trials had ended.

The trials had excluded people who were susceptible to psychiatric illness, including depression.  What was the experience like in the real world, where many obese patients also suffer from mental disturbances?  The answer was alarming: The incidence of serious depression, including suicidal ideation, bouts of nausea, stress, and anxiety, was markedly higher than in the trials.  The beneficial effects of rimonabant and its downsides both arose from the same source.

Blocking CB1 in the hypothalamus was beneficial because it diminished the desire to eat; but the drug, which was given orally, blocked CB1 throughout the body, including in those brain regions where the endocannabinoid system regulates emotion and vomiting reflexes, among others.  Which effects predominated was a matter of individual variation, and it had to be assumed that widespread use of rimonabant would put many people at risk for serious adverse consequences.

The FDA disapproved its distribution in the United States, and as reports of bad outcomes increased among patients in other countries, it was soon withdrawn from the market.  As a result, Sanofi’s stock came back to earth.

Inhibit vs. Stimulate

Some conditions, such as chronic pain, spasticity, anxiety, and the wasting syndrome associated with chemotherapy and AIDSs, can be alleviated by cannabinoids, and therefore therapeutic approaches would involve activating, not inhibiting, CB1.
For example, people self-medicate with cannabis to relieve anxiety.

The endocannabinoid system helps us deal with traumatic life experiences as a part of a normal coping mechanism—to forget it and leave the past behind.  Neuroscientists use animal models, often the “fear conditioning” test, to investigate the development of anxiety.

This is a Pavlovian training procedure in which a mildly unpleasant stimulus (a brief electric shock to the wire floor grid on which a rat or mouse is standing) is paired with a neutral tone, audible though not loud. The shock causes the animals to freeze in position—the typical response of small rodents to threatening stimuli.  When the tone is sounded alone, it elicits a bit of curiosity, then soon is ignored.  When the tone repeatedly precedes and accompanies the foot shock, the animal comes to recognize it as a bad omen and eventually responds when the tone first sounds even when the shock no longer occurs. The animal has acquired conditioned fear. Normal coping includes dissipation of the bad memories evoked by the tone (actually learning that the tone is no longer threatening), a process called “extinction,” which enables animals to cease paying the high costs of pointless responding.

Mice genetically engineered so that they do not have CB1 receptors readily acquire the fearful response, but cannot forget it as easily as do normal mice.

These mutant mice continue to respond fearfully to the tone alone, even though it no longer signals that the shock is coming, suggesting that activation of the endocannabinoid system is an essential component of the coping mechanism.
Failure to extinguish learned fearful responses may underlie posttraumatic stress syndrome (PTSD) in humans. Stimulation of the endocannabinoid system could be useful in the treatment of PTSD, as it is for treatments of cachexia and spasticity.

Inhalation vs. Digestion

The most direct route of THC administration is by smoking marijuana or other forms of cannabis. Yet purified, FDA-approved medicinal preparations of THC are available in pill form (dronabinol, pure THC marketed as Marinol®, and the analog nabilone, sold as Cesamet® in Canada). If THC is the active agent in cannabis, and approved, orally-effective THC medications exist, why the impetus for medical marijuana?

In addition to avoiding all of the legal, political, and social hassles (pot purveyors occasionally being unsavory characters), avoiding inhalation of particulates in smoke is highly desirable on its own. Why not just take a pill?

There are several reasons that some patients prefer puffing over swallowing.
One quantitatively minor factor is potential lethality. It is possible to get a fatal overdose by swallowing too many THC pills at once, whereas documented evidence of death simply from smoking too much cannabis does not seem to exist.

More common factors are speed and predictability of action, and degree of patient control. Pills must enter the digestive system, where the rate of entry of THC into the bloodstream is slow and dependent on the state of gastric filling.

It can take more than an hour for the full influence of ingested THC to be exerted on the brain, and even that time will vary depending on the timing and contents of one’s last meal. In contrast, it takes only 20 to 30 seconds for inhaled THC to reach the brain from the lungs, and its peak effects are achieved within a few minutes.

For someone suffering nausea (itself a significant impediment to the swallowing of medicine or anything else) or chronic pain, the choice is often not a difficult one.
The third factor, controllability, is another serious concern. Once a pill is swallowed, the full dose is on its way with its time-course and side effects to be played out inexorably, governed by the rates of absorption and clearance of the drug from the body.

An effective dose that has tolerable side effects in a robust middle-aged man may be too much and have intolerable psychotropic side effects in a slight, elderly woman seeking appetite stimulation to counter the weight loss associated with cancer chemotherapy.
With inhalation, patients become adept at sensing and adjusting their intake of THC via smoking (just as people become good at titrating their blood levels of nicotine when smoking tobacco).

Because smoked THC enters the brain so quickly, patients can readily detect its presence and adjust their dosing to the level that they need by inhaling less or more.
A significant downside to inhalation is that the by-products of burning plant material, particulate and chemical, are taken in and can irritate the mucous membranes of the mouth and lungs.

Even though most marijuana smokers do not smoke as much as a pack-a-day tobacco smoker does, bronchitis and the buildup of carcinogenic tars in the lungs do occur in heavy users. Studies of the occurrence of chronic obstructive pulmonary disease (COPD) from cannabis smoking are inconsistent, though.

Finally, while generally anxiety-relieving (anxiolytic) in low doses, THC can provoke anxiety and paranoia in high doses, responses that seem exacerbated with inhalation, probably because it acts so quickly.

Some of the drawbacks of smoking cannabis may be circumvented by the use of vaporizers somewhat similar to “e-cigarettes” (electronic cigarettes) that use heating elements to vaporize a liquid nicotine solution.

Cannabis vaporizers heat the plant material so that volatile compounds, such as THC, are given off before actual burning and the associated release of particulates, toxins, and carcinogens occurs.

Such devices deliver about as much THC as is found in smoke and are often better tolerated than smoking, although irritation of the mouth and throat are occasional problems.

Like e-cigarettes, the designs, efficacy, safety, regulation, and legality of these devices are in flux, but they do provide a potential option for cannabis users who prefer inhalation.

Variation (polymorphisms) among people in the genes encoding CB1 receptors and other endocannabinoid system components affect their cannabinoid drug sensitivity, as well as their susceptibility to disorders related to disturbances of the endocannabinoid system.

Links between CB1 polymorphisms and schizophrenia, autism-spectrum disorders, and PTSD have been suggested but remain controversial. Sorting these relationships out is an important task, since the information gained will contribute to the future ideal of personalized medicine.

Would Having an Entourage Help?

A final reason for the popularity of smoking over the purified oral THC preparations is subtle and not well understood. For many people, pure THC in pill form is aversive; the unpleasant sensations, “dysphoria,” cause patients to not take their pills.

Smoking cannabis is less offensive for some of these patients, suggesting that something besides THC is involved. THC is the only psychotropic cannabinoid, but one or more of the nonpsychotropic cannabinoids could modulate or soften the impact of pure THC in several ways: They might act as part of an “entourage,” unable to activate CB1 themselves but capable of modifying THC’s ability to do so.

Alternatively, nonpsychotropic cannabinoids might influence other components of the endocannabinoid system (synthesis, uptake, or degradation), and thus alter availability of endocannabinoids, which compete with THC for access to CB1, and thereby indirectly tweak THC’s actions. But interactions with the endocannabinoid system are not the only possibilities.

Nonpsychotropic cannabinoids can affect conventional neurotransmitter receptors and ion channels that are entirely unrelated to the endocannabinoid system.  (They are “cannabinoids” because they come from the cannabis plant, not because they necessarily have anything to do with CB1, CB2, or the ECS in general.)

Cannabidiol (CBD) is a major nonpsychotropic cannabinoid, and is almost as abundant as THC.  Interestingly, while the CBD:THC ratio varies in different strains of cannabis, the total amount of cannabidiol plus THC across strains is roughly constant.  The more THC, the less cannabidiol, and vice versa.

The proportion of CBD:THC is selected for in cannabis plant-breeding programs. Cannabidiol can inhibit CB1 (and CB2) directly, and this may diminish THC’s CB1-mediated undesirable actions, which are dose-related.  For example, cannabidiol blunts the anxiogenic and psychotropic side effects of THC.

In addition to synergistic actions, cannabidiol by itself is anxiolytic, and can reduce inflammation and blood pressure.

A mucosal spray, Sativex® (GW Pharmaceuticals), a botanical extract of cannabis plants, has a standard CBD:THC ratio of 1.  In Canada, the United Kingdom, and other countries (not yet the United States), Sativex® is available for the treatment of the pain and spasticity of multiple sclerosis.

The anticonvulsant properties of cannabis have been known for centuries.  A dramatic account of such action recently received widespread media coverage.  A young child suffering from an intractable form of childhood epilepsy called Dravet syndrome had been unsuccessfully treated with a battery of epilepsy therapies for years since her first seizure at 3 months old.  By age 5, she was having up to 300 seizures per day, and experiencing mental and physical developmental stagnation.  Her prospects were grim and her parents desperate.  With the approval of two doctors, they tried adding an oil extract of cannabis to her food. Amazingly, her seizures immediately dropped to a few per month, an improvement that has persisted for a year, and her normal development resumed.

A notable feature of this case, which has been repeated in other similarly afflicted children, is that her cannabis extract is from a strain (called “Charlotte’s Web”) that is very low in THC and high in cannabidiol.

To what extent this positive outcome is attributable to the low THC, the high cannabidiol, or the combination of the two is unknown.  A different nonpsychotropic cannabinoid, cannabidivarin, reduces seizures independently of CB1 in animal models, and this property is not improved by the presence of THC.

Turning On (or Off)

CB1 receptors exist on nerve fibers outside of the central nervous system, and there they also direct communications traffic.  Psychotropic side effects of cannabis are caused exclusively by turning on or off brain CB1s.
Therefore one strategy is to develop CB1 agonists or antagonists that can be given orally but that do not cross the blood-brain barrier (a membranous cellular fence that bars certain chemicals present in the circulation from getting into the brain).  CB1s in fat and other tissues are thought to contribute to obesity, and a peripherally restricted CB1 antagonist could be beneficial in weight control.

Conversely, cannabinoids are good pain relievers that work in part by stimulating CB1s on peripheral pain sensory neurons.  When activated, these CB1s block transmission of the pain signals to the brain—basically what topical anesthetics like novocaine do—and pain signals unable to reach the brain are not felt.  CB1 agonists or antagonists that are restricted from the brain could be quite useful in conditions that do not arise from within the central nervous system.

What about manipulating other components of the endocannabinoid system?

Rather than stimulating CB1 with drugs, the endocannabinoids can be pressed into service artificially.  Once released, endocannabinoids, like other chemical messengers, are quickly taken back up into cells or otherwise inactivated, which preserves the integrity of the signaling process.

Inhibiting uptake and degradation therapeutically offers the advantage of increasing the endocannabinoid levels, and thereby activating CB1, in those regions in which the messengers are already being mobilized by brain activity itself.  Rather than indiscriminate activation of CB1s everywhere for long periods of time, only certain groups of receptors would be activated and only when and where called for naturally.

With a drug that inhibits the enzyme (fatty-acid amide hydrolase, FAAH) that inactivates the endocannabinoid, anandamide (but not 2-AG), levels increase, and an analogous approach inhibits the major degradation enzyme for 2-AG, monoglyceride lipase (MGL) and 2-AG levels rise. Elevations in endocannabinoids in this way can have beneficial effects.

Unfortunately, there are still problems: In addition to activating CB1, anandamide turns out to be an excellent activator of a another receptor, TRPV1, a noncannabinoid receptor that actually heightens anxiety, so globally elevating anandamide has complex effects.
Drugs that inhibit both FAAH and TRPV1 could be helpful in some cases.

Meanwhile, globally elevating 2-AG by decreasing its breakdown overloads the endocannabinoid system, which responds by causing a protective shutdown, or down regulation, of many CB1s in the brain.

This is counterproductive if the goal is stimulation of the endocannabinoid system.
An encouraging development along these lines is that the peripheral pain signals can be quashed by raising anandamide and 2-AG levels only near the site of origin (a rat’s paw), where a painful stimulus was given. This means that the local peripheral CB1 and CB2 receptors in the paw were effectively turned on by the elevation in endocannabinoid levels resulting from prevention of their breakdown.

In this case, pain relief free of psychotropic side effects should be possible with degradative enzyme blockers designed to stay out of the central nervous system.

Finally, a possibility that has gotten little attention is the targeting of conventional neurotransmitter systems that stimulate the production of endocannabinoids.
For example, glutamate is the major excitatory neurotransmitter in the brain, and one subtype of glutamate receptors (group I mGluRs) potently mobilizes endocannabinoids.

A genetic disease that causes mental retardation, fragile X syndrome, has long been associated with excessive activity at the same glutamate receptors, which could be related to the excess production of endocannabinoids at inhibitory synapses in a mouse model of the disease.

Perhaps combining modest inhibition of both CB1 and group I mGluRs would be a way of tapping the therapeutic potential of the ECS, while avoiding some of its problems.

What Is in Store?

The endocannabinoid system is powerful and nearly ubiquitous in the nervous system.
The cannabinoid receptors dispersed throughout many brain regions are responsible for regulation of numerous aspects of neuronal activity, and account for the bewildering variety of behavioral and psychological effects caused by THC.

Depending on the nervous system regions and maladies involved, either stimulating or inhibiting the endocannabinoid system could have beneficial effects.

A great deal of attention is being given to incorporating nonpsychotropic cannabinoids into medicinal preparations, although in most cases the actual effects of these agents on the nervous system are unknown. For some purposes, drugs that are restricted to acting on peripheral cannabinoid receptors, and are prevented from entering the central nervous system, could be effective.

Finally, therapeutic strategies aimed at developing regionally selective targeting of endocannabinoid system components, perhaps in combination with agents that affect conventional neurotransmitter systems, or nonpsychotropic cannabinoids, offer promise for future advances.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/…
-------------------------------------------------------
Graphic from "Nature Reviews: Cancer"
October 2003
"Cannabinoids: Potential Anticancer Agents"
http://americanmarijuana.org/Guzman-Cancer.pdf

Tuesday, April 28, 2015

Looking at the Truth of "Passover"

IMG 2194  Daynes Party
Fire is spoken of as tongues of fire ...

The deep past is littered with holy days and festivals that have long since either lost their true meaning or the meaning has been purposely concealed for as they say the benefit of the minions.  The history as told by the corrupt half there book called BIBLE does not do the story justice ... according to many learned amongst us, this passover is a reference to an astrological event which was then Christianized by the Roman Church post the adoption of the festival by the false Jews at that time.
The Passover is the annual passing over of the sun from the southern to the northern hemisphere, according to primitive ideas concerning astronomy. The sacrifice of the lamb at this period was practised by the pagan Greeks who regarded the vernal equinox as the annual rebirth of the savior god. The ceremony of Easter is the perpetuation of pagan equinoctial rites.
Manly P Hall
For instance, when we read of "lamb's blood" being daubed on the portals of doorways, we are being told of this constellational change. When we hear of the Jewish priests blowing the "ram's horn" at the Eastern gate of the temple, we are being told of it, and when we hear of the sacrifice of the "Paschal Lamb," the story is the same.

The very term "Passover," originally referred to this action of the sun literally passing over the hypothetical boundaries of the signs of the zodiac. The most important biblical rendition of the astrological story and dilemma concerns the time of the exiled Children of Israel at Mount Sinai. It was here that the people returned to the worship of the "golden calf," that is of Taurus.

As the Book of Exodus relates, Moses was furious with his people's recalcitrance and smashed the tablets with his Yahwistic (Atonist) commandments on them.


Michael Tsarion / The Irish Origins of Civilization, Volume 2
Free Bible illustrations at Free Bible images of Moses and the golden calf. (Exodus 32): Slide 7
Add caption
From Wikipedia ....
Pentecost (Ancient Greek: Πεντηκοστή [ἡμέρα], Pentēkostē [hēmera], "the fiftieth [day]") is the Greek name for Shavuot, the Feast of Weeks, a prominent feast in the calendar of ancient Israel celebrating the giving of the Law on Sinai.
This feast is still celebrated in Judaism as Shavuot. Later, in the Christian liturgical year, it became a feast commemorating the descent of the Holy Spirit upon the Apostles and other followers of Jesus Christ (120 in all), as described in the Acts of the Apostles 2:1–31.

For this reason, Pentecost is sometimes described by some Christians today as the "Birthday of the Church".

In the Eastern church, Pentecost can also refer to the whole fifty (50) days between Easter and Pentecost, hence the book containing the liturgical texts for Paschaltide is called the Pentecostarion. The feast is also called White Sunday, or Whitsunday, especially in England, where the following Monday was traditionally a public holiday. Pentecost is celebrated fifty days (i.e. 49 days with the first day counted, seven weeks) after Easter Sunday, hence its name.[2] Pentecost falls on the tenth day after Ascension Thursday (which falls 40 days after Easter).
The Pentecostal movement of Christianity derives its name from the New Testament event.
Passover or Pesach (/ˈpɛsɑːx, ˈpsɑːx/; from Hebrew פֶּסַח Pesah, Pesakh), is an important, biblically derived Jewish festival.
The Jewish people celebrate Passover as a commemoration of their liberation by God from slavery in Egypt and their freedom as a nation under the leadership of Moses. It commemorates the story of the Exodus as described in the Hebrew Bible especially in the Book of Exodus, in which the Israelites were freed from slavery in Egypt.

According to standard biblical chronology, this event would have taken at about 1300 BCE (AM 2450).

Passover commences on the 15th of the Hebrew month of Nisan and lasts for either seven days (in Israel) and for Reform Jews and other progressive Jews around the world who adhere to the Biblical commandment or eight days for Orthodox, Hasidic, and most Conservative Jews (in the diaspora).

In Judaism, a day commences at dusk and lasts until the following dusk, thus the first day of Passover only begins after dusk of the 14th of Nisan and ends at dusk of the 15th day of the month of Nisan.

The rituals unique to the Passover celebrations commence with the Passover Seder when the 15th of Nisan has begun. In the Northern Hemisphere Passover takes place in spring as the Torah prescribes it: "in the month of  spring" (בחדש האביב Exodus 23:15).

It is one of the most widely observed Jewish holidays.
CALENDAR:

Nisan
(or Nissan) (Hebrew: נִיסָן‎, Standard Nisan Tiberian Nîsān) on the Assyrian calendar is the first month and on the Hebrew calendar is the first month of the ecclesiastical year and the seventh month (eighth, in leap year) of the civil year.

The name of the month is Babylonian; in the Torah it is called the month of the Aviv, referring to the month in which barley was ripe. Assyrians refer to the month as the "month of happiness." It is a spring month of 30 days. Nisan usually falls in March–April on the Gregorian calendar. In the Book of Esther in the Tanakh it is referred to as Nisan.

Images @ Eminpee Fotography- fire

Monday, April 27, 2015

Vaccinating the Babies in the new Millenia.

IMG 0317 Beautiful Bentley


Today to vacinate your baby is to play russian roulette with your little treasures very life.  So many children have died of SIDS and other strange things that are now being attributed to the new types of vaccinations that are derived from Genetically Modified Sources.
The following is an extract or a snapshot of what is going on in the US with the vaccination issue.  This should highlight why so many  mothers in Australia are opting out of the program despite the Federal Government using Family Tax Benefit denial to mothers who refuse to vaccinate.  This is a very low and inhumane way to deal with a serious issue.  Tony Abbott is on record as saying those mums who refuse are guilty of neglect.  This is ludicrous on all levels.
According to the entire mainstream media in the United States -- which is 100% controlled by corporate interests -- vaccines never harm anyone and are perfectly safe to inject into children in unlimited quantities. This dangerous, inhumane "Vaccine Injury Denialism" is rampant across the corporate-controlled media, which contributes to the deaths of innocent babies and children by refusing to acknowledge the truth that vaccines kill and injure children on a regular basis.

Just recently, in fact, the UK government agreed to pay $90 million to victims of the swine flu vaccine. That vaccine caused permanent brain damage to over 800 children across Europe. The truth is that vaccines regularly harm and even kill innocent children, most likely because of the toxic chemical adjuvants and preservatives they still contain.
Images @ Eminpee Fotography

Sunday, April 26, 2015

The World Tree - YGGDRASIL

IMG 6465  Interesting Reds at Dawn.
Add caption
The trees are more than they appear!  This is something I call innate knowledge and the reason why I tend to talk to them like they are friends, wise friends who stand still.  Well it appears to us they are stationary but in fact they never stop moving either and trees observe everything that occurs for a long time equating to many of our life times if left to grow in peace.

The World Tree
Ragnarok is upon us all now and none of us can escape what is about to happen to any of us.  In the interim if you have prepared for this you will be spared if your heart is not found lacking.   The trumpet has been blown.

Erika Hansen - Image
 The fate of Yggdrasil during the events of Ragnarök.

In Norse mythology, Yggdrasil (/ˈɪɡdrəsɪl/ or /ˈɪɡdrəzɪl/; from Old Norse Yggdrasill, pronounced [ˈyɡːˌdrasilː]) is an immense tree that is central in Norse cosmology, in connection to which the nine worlds exist.

Yggdrasil is attested in the Poetic Edda, compiled in the 13th century from earlier traditional sources, and the Prose Edda, written in the 13th century by Snorri Sturluson.

In both sources, Yggdrasil is an immense ash tree that is central and considered very holy. The gods go to Yggdrasil daily to assemble at their things. The branches of Yggdrasil extend far into the heavens, and the tree is supported by three roots that extend far away into other locations; one to the well Urðarbrunnr in the heavens, one to the spring Hvergelmir, and another to the well Mímisbrunnr. 

Creatures live within Yggdrasil, including the wyrm (dragon) Níðhöggr, an unnamed eagle, and the stags Dáinn, Dvalinn, Duneyrr and Duraþrór.

Conflicting scholarly theories have been proposed about the etymology of the name Yggdrasill, the possibility that the tree is of another species than ash, the relation to tree lore and to Eurasian shamanic lore, the possible relation to the trees Mímameiðr and Læraðr, Hoddmímis holt, the sacred tree at Uppsala, and the fate of Yggdrasil during the events of Ragnarök.  Wiki
https://www.youtube.com/playlist?list...
Images @ Eminpee Fotography

Saturday, April 25, 2015

Killing days Sarifice of 100 years ago

 IMG 8906 Uncle Lewis's Fire

Sunday, 20 December 2015, marks 100 years since the last Australian troops evacuated Gallipoli  and this year they are going all out because it was century ago this occurred. It is a celebration of sacrifice no less.

This day in Gallipoli where so many men lost their lives in a veritable blood bath was apart of esoteric practices and this fate occurred during the eternal sacrifice days I have come to know as the Killing Days. 

These days span from the 19th April to Walpurgisnacht on the 1st of May.  On the first of May people dance the Maypole corresponding to the truth of our existence.

Walpurgis Night is the English translation of Walpurgisnacht [valˈpʊʁɡɪsˌnaχt], one of the Dutch and German names for the night of 30 April, so called because it is the eve of the feast day of Saint Walpurga, an 8th-century abbess in Francia.

In medieval German folklore the evening preceding the feast day of St. Walpurgis, is when witches congregated, especially on the Brocken.


Walpurgis4
Lewis Morrison as “Mephistopheles” in Faust! – “The Brocken”. Poster for a theatrical performance of Goethe’s play showing Mephistopheles conjuring supernatural creatures on the German mountain, the Brocken (or Blocksberg). 1887. Lithograph by Dickman, Jones & Hettrich.
Johann Wolfgang Von Goethe's  FAUST  Pts one and two of Walpurgis Night
Summary
It has been nearly a year since Valentine's death and Faust has again abandoned Gretchen. Now it is Walpurgis Night (April 30th), the time of the annual gathering of witches and spirits at the top of the Brocken in the Harz Mountains (located in central Germany) to celebrate a satanic orgy. The mountain top is covered with swarms of demons dancing and singing. The tension rises to a mad crescendo of evil as Mephisto guides Faust through his fiendish assembly, introducing him to all the infernal spirits of medieval legend, and inducing him to participate in their rites. While coupled in an erotic dance with a young female witch, Faust suddenly notices a mouse coming out of his partner's mouth. The shock of this causes him to remember Gretchen. He has a vision of her in chains, becomes distressed, and starts to wander away. Mephistopheles immediately springs into action. He gives a fanciful interpretation of the vision and tries to distract Faust by leading him to a theatre on the mountainside.
Analysis
Faust has been brought to the Walpurgis celebration to complete his degradation and make permanent his lapse from morality. This episode can be interpreted symbolically as the descent into Hell promised in the "Prelude in the Theatre." The atmosphere of the scene is one of evil, black magic, and fantastic confusion. The witches and demons that Faust encounters are incarnations of all the many facets of evil. Their characterizations or satanic functions mirror many earlier incidents in the poem and bring home a bitter lesson to Faust about the true nature of his "new life." Here on the mountain Faust is made to face the awful reality of his own degeneration, but at the last moment his moral sensibility makes a final effort to assert itself. He remembers Gretchen and the love for her which was his first real participation in life.

Images @ Eminpee Fotography

Friday, April 24, 2015

Contemplate the costs!

Money is what is driving our society today.  Greed is the material existence of the masses and this manifests on the evolution of the planet.  The evolution becomes dense and low resonant vibrations are ever evident, getting lower and lower until everyone forgets who they are in their divine nature over the great cycle.

Australian One Hundred Dollar Notes ... lots of the John Monash's.
We have just moved house.  This action can be fraught with difficulty where finances are concerned for the ordinary person.  It is an expensive practice to move residence.  All aspects of this act cost an arm and a leg so to speak. 

The moving truck was a figure that would shock the socks off most and this prevents many from moving from a place that no longer resonates with them.  Staying put only makes you sick if you are unhappy.  It is wise to move the soul on as nothing in the universe rests and we should imitate the great universe for happy living.

It should shout to all who can see that my word is gold because this is me in the great act of "thinking then acting" as a part of the All.   I said I would move in five years and it is exactly to the day five years.  The All creates and manifests and the quicker people realize this creative instinct in themselves the better off we will all be as a functioning entity.  I recognize this and I wish others would also.

ON THE MONEY

On the history of this particular issue of $100 note.  The polymer issue was designed by Bruce Stewart, and features portraits of soprano Dame Nellie Melba and engineer and First World War general Sir John Monash.  Monash was born in Dudley Street, West Melbourne, Victoria, on 27 June 1865, the son of Louis Monash and his wife Bertha, née Manasse.  He was born to Jewish parents, both from Germany (the family name was originally spelt Monasch and pronounced with the emphasis on the second syllable), living in Krotoschin in the Kingdom of Prussia, now Krotoszyn in the Greater Poland Voivodeship, Poland. 

John Monash 1.jpg
Sir John Monash
Order of the Bath-Badge Template.JPG
Add caption
ORDER OF THE BATH

The family spoke German as their native language, and some sources describe them as being of German origin. John Monash was awarded the Order of the Bath for his military Service and to me it is the old guard raising its war monger head in a family in Australia and here is further proof of this.  The Order consists of the Sovereign (currently Queen Elizabeth II), the Great Master (currently The Prince of Wales), and three Classes of members:
  • Knight Grand Cross (GCB) or Dame Grand Cross (GCB)
  • Knight Commander (KCB) or Dame Commander (DCB)
  • Companion (CB) (Wiki)
The title of the Order is late medieval in origin. It arose from the ritual washing (inspired by the washing of baptism), a symbol of spiritual purification, which formed part of a knight's preparations for the conferment of knighthood.

The honour was not conferred until the candidates had prepared themselves by various rituals designed to purify the inner soul by fasting, vigils and prayer, and cleansing themselves by bathing.
The earliest mention in an official document, after the crowning of William I, of the ceremony of bathing at the creation of a knight was that of 15-year-old Geoffrey count of Anjou (later husband of Mathilda) in 1128. 
Images @ Eminpee Fotography

Thursday, April 23, 2015

Exploitation is the driver, and assimilation is the servant.

The various State Governments in Australia are complying to genocidal policies which have in turn been metered out by the Australian Federal Government.

IMG 9420.1 Uluru Dreaming 2012
Remote Community at Uluru is Mutujulu
These greedy colonists want the land for Uranium mining and they will stop at nothing to get this land.  There is zero concern for ancient works of art that are more than precious in nature by these greedy whores.  They want to erase all links to anything that shows these people have been here since the dawn of time albeit that is a very long long time.  To argue about the exact length of time is perilous and useless because we all know it was for at least 70 thousand years plus.

Shutting remote communities in Western Australia, Northern Territory and Queensland is nothing shy of a land grab and the desire to ignore any Aboriginality facts by these faceless men is a sign of substantial greed and avarice and their filthy ego's are similarly stroked by such a land grab from such oppressed peoples.

These policies move the first people from their spiritual homelands and it gives mining companies the illegal rights to bulldoze cave art and sacred areas.  The flow on effects of this are being hidden and the effects are being hidden by illusions of media.  The finite minds eat this rubbish up as truth and therefore unwittingly are apart of this extremely serious problem.

This is a travesty that is on par with the burning of the libraries at Alexandria a few thousand years ago.  That burning was a similar attempt to cover the truth of who we really are and what our divinity nature actually affords us if we recognize this in ourselves and in others.  They covered so much wisdom then and they are bringing this same oppression on all and the white assimilation is none less this and largely goes unnoticed by the masses.  They will be the ones who will be the most grossly effected by what is coming, it is their own hand which has put them there.  They refused to believe absolute truth in preference for what they thought was truth but it was merely relative truth for themselves only and the real truth was passed over by them.   The material plane is playing out nature in all of its glorious self.

It is the time for great suffering and with that there will be great joy not dissimilar to the birthing pains of childbirth.

Please read The Stringer article "Here is part of the list of threatened Homelands – “remote communities”  by Gerry Georgatos

Images @ Eminpee Fotography

Wednesday, April 22, 2015

A New Chapter begins on the New England Highlands!

22nd day of the month and we unpack the Truck.... Number 22 is a number of power and accomplishment. 

Raleigh Removals - Dean and Jeff
I was excited this unpacking day fell on April 22.   This is because those two's do show up to me often.  The number 22 is a significant number which and is 2 appearing twice and this strengthens the message it is carrying.  The # 2 relates to our Divinity Path and our souls journey of learning.   Having this number significant shows the self to keep doing the great work.  The clear message here is to keep working consistently on my divine purpose which is the infinite consciousness (God) experiencing itself through creation.
  
Most everything was packed into the substantial shed that we now have.  It comes complete with a cement floor and lining and so our chatels were taken in there straight from the truck.  The old black hand painted fridge and my sadly rusting washing machine did however come in today while the boys were here to help as both are quite heavy and awkward to cart around alone. 

We have a lot of cleaning to finish off to be able to live alright, albeit a temporary clean for now.  So today while Brice helped the boys unpack the truck, I concentrated on cleaning the bathroom from top to bottom. 

After all of the hard work we carried out today we needed a great shower and a clean good bed so I was diligent and washed the walls in our bedroom, mopped the uncovered wooden floors and then  we put up our bed and made it with all the doonas we owned.

I felt good because I had cleaned the bathroom and toilet to a spick fashion. The kitchen too was given a fair good clean bench wise.  Tomorrow we will clean all of the cupboards.  Today was simply a huge day from start to finish too and today also started at about 4:30am.

When the removal boys arrived at our house this morning they were able to convey to us what had happened with the major weather event south of us where we are here at our beloved Dungog.

Dungog floods
Four people lost their lives in an absolute freak storm for that area.  It kind of shook Jeff Guest the removals guy up because only yesterday I was telling him the reason why we were leaving the coast to get to higher ground. 

I told him it was vitally important to me to get to a place where I could feel safer.    I  have been predicting strange things weather wise for some years now numbering about three years.  In my opinion being on the edge of the Pacific Ocean on a cliff which was really a midden  was not where I wanted to weather this weather event I think is on route.  My past recurring dreams of water hitting Dorrigo Mountain was a large contributing factor along with the fact I am a poor swimmer.
Images @ Eminpee Fotography

Tuesday, April 21, 2015

Its Tidy Tuesday and it's the gigantic "Moving Day"!



Biggest shout out to Jeff and Dean from Raleigh Removals at Raleigh NSW... these guys were awesome.  So awesome in fact, they packed my handbag in the front of the truck.  Lunch time came and I looked for my bag and realized it must have been packed so we unpacked the truck to find it and there it was. 

That was just one of those funny things that day that made arriving at our new house happen at night time in the freezing cold in the dark.  It was a lot of work that day, a huge drive at the end of the day and a cold arrival but the spirits were red hot in all of us. 

Excitement was the order of the entire day.  Phoenix and Sooty were transported safely to their new home.   Sooty went with Aunty Kay in her vehicle and Phoenix travelled with us in our vehicle. Once at Guyra we stopped to check on how things were going with Sooty.  Things were pretty difficult and so we inherited Sooty our black female cat into our car as well.  She who incidentally would not move from Aunty Kay's lap the entire previous part of the trip from Urunga. 

The cleaning of the house was all done as awesome as we could.  We had done a lot of preparation while waiting to leave that made that part easy.  Our neighbors on both sides were simply amazing with their help and their well wishes. 

Ronny mowed our lawn for us as it rained right up to our leaving which made it impossible to remedy ourselves and so that was a blessing indeed.  My friends all pitched in to help on last days.  Suzie taking my largest crows nest that was simply huge and Ian taking all of the others home to Kathy made that easier for us.  Easier for me to part with them to friends too.


 So we arrived at our new home and I slept in the tent again in the lounge room and Aunty Kay on the camp stretcher and Brice in the chair.  It is a wonder we didn't freeze right there and then (jokes).  We all arrived to our destination safely thank the mightiness of the stars above us.  

Aunty Kay was an absolute legend from start to finish with keeping us all on task and continuity of work for the entire day from 5am this morning.  I was touched to see Gail and Shelby and for Shelby to see the truck filling up so she knew I had moved house and not run away from her.  Gail gave me a lovely present with the cutest little notebook with tiny pen...  I loved this and I was sad to say farewell to our many years of fun together in Urunga.  Our Christmas's every year together since we moved down there from Bellingen.  Playground fun with Shelby and her first swim at the beach are the things that will tug most at my heart strings.

My own children are grown up now.  My youngest Montana-Star visited with her partner Anaan last evening for a few hours and I can barely put down here how much I will miss being only ten minutes away from them.  Life goes on and they will probably head out into the great wide world themselves at some stage like most of the young guys do,  like we did also.  

So ended this big huge gigantic day for Brice and myself as we left our home for the last few decades.  This is a huge change and we both needed this for us to move on from the sadness of the past and the loss of so much.

Images @ Eminpee Fotography

Monday, April 20, 2015

No jab, no pay.

IMG 2653

The religious loophole for not vaccinating has now been closed.  People can no longer say its on religious grounds. There are No Exemption's except for medical reasons.
 
No jab, no pay. 


Families will stand to lose up to $15 000 for every child of family benefits if they do not vaccinate.

Images @ Eminpee Fotography - Indigenous mum n bub.

Sunday, April 19, 2015

Trials of Medical Cannabis announced for three states.


Medical Marijuana
Image: Log Home Finishing
The Queensland and Victorian state governments have joined forces with New South Wales to take part in medicinal cannabis clinical trials.
The NSW Government introduced the scientific trials last year to help treat patients with drug-resistant and uncontrollable epilepsy.   Read Full Story here ABC News

 “Prior to the Coag meeting I was fortunate enough to have a conversation with [NSW] premier Mike Baird and [Victorian] premier Daniel Andrews. I would like to place on the record my thanks to premier Mike Baird for his leadership in relation to this issue.” Annastacia Palaszczuk   The Guardian
Medical Marijuana

IMG 7050
Cannabis

Then there are the stupid opportunistic companies thinking this substance will work in pill form, are they kidding.  This the moronic attittude of the sheeple.   It won't have the magical effects of the whole plant in its natural form.  

Read more here  http://www.businessinsider.com.au/australias-first-medical-marijuana-company-will-kick-off-its-farm-to-pharma-strategy-by-releasing-a-dope-pill-2015-3

And a mining company as well... that one topped the bad bunch.
Capital Mining makes bid to be first to grow medicinal cannabis
 
Images @ Eminpee Fotography